EP0395758B1 - Separate storage container - Google Patents
Separate storage container Download PDFInfo
- Publication number
- EP0395758B1 EP0395758B1 EP88908369A EP88908369A EP0395758B1 EP 0395758 B1 EP0395758 B1 EP 0395758B1 EP 88908369 A EP88908369 A EP 88908369A EP 88908369 A EP88908369 A EP 88908369A EP 0395758 B1 EP0395758 B1 EP 0395758B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- chamber
- storage container
- piercing
- separate storage
- container according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000003814 drug Substances 0.000 claims abstract description 40
- 238000004891 communication Methods 0.000 claims abstract description 13
- 239000004033 plastic Substances 0.000 claims abstract description 12
- 239000002904 solvent Substances 0.000 claims abstract description 10
- 239000000126 substance Substances 0.000 claims description 7
- 229920003002 synthetic resin Polymers 0.000 claims description 5
- 239000000057 synthetic resin Substances 0.000 claims description 5
- 229920005992 thermoplastic resin Polymers 0.000 claims description 4
- 238000000071 blow moulding Methods 0.000 claims description 3
- 239000007769 metal material Substances 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 230000002093 peripheral effect Effects 0.000 claims description 3
- 238000000465 moulding Methods 0.000 claims description 2
- 229940079593 drug Drugs 0.000 abstract description 6
- 238000004090 dissolution Methods 0.000 abstract description 2
- 238000000926 separation method Methods 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 27
- YRMCBQLZVBXOSJ-PCFSSPOYSA-N (e)-3-[(6r,6as)-4-hydroxy-6-methoxy-3-methyl-11-oxo-5,6,6a,7-tetrahydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]prop-2-enamide Chemical compound CO[C@H]1NC2=C(O)C(C)=CC=C2C(=O)N2C=C(\C=C\C(N)=O)C[C@@H]12 YRMCBQLZVBXOSJ-PCFSSPOYSA-N 0.000 description 7
- 238000001990 intravenous administration Methods 0.000 description 6
- 238000010276 construction Methods 0.000 description 4
- 229910052782 aluminium Inorganic materials 0.000 description 3
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- -1 polypropylene Polymers 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2093—Containers having several compartments for products to be mixed
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D81/00—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
- B65D81/32—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents for packaging two or more different materials which must be maintained separate prior to use in admixture
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/10—Bag-type containers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/2006—Piercing means
- A61J1/201—Piercing means having one piercing end
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/202—Separating means
- A61J1/2027—Separating means having frangible parts
Definitions
- the present invention relates to a container for separately containing two or more substances, and more particularly, to a separate storage container in which a solvent, such as a solution, in a storage chamber is fed into a solute containing member which contains a solute, such as a powered or liquid medicine, so that the solute, such as the powdered or liquid medicine, can be mixed and sterilely dissolved.
- a solvent such as a solution
- solute such as a powered or liquid medicine
- a suitable amount of a solution such as a physiological saline solution or 5 % grape sugar injection solution, is sucked in by means of an injector, and the needle of the injector is stuck into a solute vessel containing a powdered medicine, thereby injecting the solution. After the powdered medicine is dissolved, the solution is sucked in again to give a patient an injection.
- a solution such as a physiological saline solution or 5 % grape sugar injection solution
- a solute vessel containing a powdered medicine and a bag stuffed with a solution are sterilely connected by means of an adapter which constitutes communication means holding a piercing needle and a frangible portion, the solution is injected into the solute vessel which contains the powdered medicine, thereby dissolving the powdered medicine, and the resulting solution is returned to the bag to subject a patient to an intravenous drip.
- a sleeve which is disposed so as to surround the piercing needle and is formed of a flexible material which expands and contracts as the needle moves.
- a solute vessel containing a powdered medicine, a bag stuffed with a solution, and an empty bag are sterilely connected to one another by means of an adapter which includes a needle and a frangible portion.
- the solution is put into the solute vessel to dissolve the powdered medicine, whereupon an antibiotic or the like is fully dissolved by using the empty bag as an air vent.
- the resulting solution is returned to the bag to subject a patient to an intravenous drip.
- vessels must be provided separately for the solution, injector, and powdered medicine, and must be operated in equipment for sterile work, such as a clean bench, so that the operation is troublesome, and there is a possibility of external bacterial contamination.
- equipment for sterile work such as a clean bench
- there is no need of the sterile equipment, such as a clean bench since no means is provided for positively keeping the prick portion of the solute vessel containing the powdered medicine separated from the piercing needle on the adapter when not in use in a normal state, so the solute vessel and the adapter may possibly be connected by mistake.
- the connecting operation is troublesome for an operator, and the construction of the adapter is complicated.
- the object of the present invention is to provide a medicine storage container which eliminates the various problems of the prior art separate storage containers described above, and which,despite its simple construction, can positively keep a piercing section of one containing member containing one substance separated from a piercing element capable of piercing the piercing section as required, when not in use in a normal state, and can enable an operator to perform the piercing operation easily and securely, when in use, so that a chamber for the one containing member and a chamber for the other containing member containing the other substance are sterilely connected to effect required mixing (dissolution), and which is easy to handle.
- the present invention is based on the common arrangement disclosed in the second and third and fourth prior art examples.
- the invention is premised on an arrangement which comprises the features of the preamble of claim 1.
- the holding means can positively keep the piercing element of the communication means separated from the piercable section of the second containing member, so that an unexpected wrong piercing operation can be prevented.
- the holding means is plastically deformed by somewhat strongly applying the external force or an operator's manual force to a value greater than the predetermined value, so that the piercing operation can be effected, and the pierced state can be securely maintained by the plastically deformed holding means.
- the holding means has a rigidity so as to be able to maintain its plastically deformed state when subjected to the above external force of a value greater than the predetermined value, thereby holding the pierced state of the piercing element.
- the separate storage container of the present invention is simple in construction due to its few components, and its communicating portion, which constitute the communication means, is sealed to be kept sterile. Further, a guide cover, which constitutes the holding means, cannot be plastically deformed unless it is subjected to an axial external force of a value greater than the predetermined value, so that a piercing needle, which constitutes the piercing element of the communicating portion, can hardly be unexpectedly run through the piercable section by mistake. Since there is no empty bag or the like, moreover, the dissolving operation is easy.
- the predetermined value of the external force to subject the holding means to the plastic deformation is set to be greater than the piercing resistance of the piercing element piercing the piercable section, e.g., to 3 kgf or more, preferably within the range of 3 kgf to 5 kgf, further preferably to 3.5 kgf.
- the holding means is composed of a bellows-like guide cover integrally formed from thermoplastic resin by blow molding, for example.
- blow molding in particular, outwardly projecting crest portions of the bellows-like guide cover can be easily formed thinner than inwardly recessed bottom portions, so that a desirable property for the guide cover can be obtained.
- Fig. 1 is a perspective view of a medicine storage container as a separate storage container of the present invention wrapped in a package
- Fig. 2 is a perspective view of the medicine storage container.
- numeral 1 denotes the medicine storage container
- the medicine storage container 1 comprises a storage chamber 2 and a housing chamber 3 which are integrally formed of a flexible synthetic resin sheet and are independent of each other.
- This medicine storage container 1 is entirely covered by a rectangular package 4, which ensures the stability of a solution S (mentioned later) for use as a solvent sealed in the storage chamber 2.
- the storage chamber 2 contains 50 to 100 ml of the solution S, e.g., a physiological saline solution or 5 % grape sugar solution.
- a discharge port 5 is provided at the lower portion of the storage chamber 2, and further, an aluminum cap 6 is fitted on the discharge port 5 so that the solution S cannot run out.
- a hole 1a which is used to hang the container 1 on a hanger 14 of a transfusion stand 13 mentioned later, is formed at one end portion of the container, and a boundary portion 1b for dividing the two chambers 2 and 3 is formed at the middle portion.
- a communicating section 9 as communication means is disposed between the upper portion of the storage chamber 2 and the lower portion of the housing chamber 3.
- the communicating section 9 has a separable closing section 7 located in the storage chamber 2 and a bottle needle or piercing needle 8 as a piercing element at the distal end thereof which is located in the housing chamber 3.
- This communicating section is in the form of a cylinder closed at its end portion in the storage chamber 2, and a notch is formed in the inner peripheral surface so that the closing section 7 can be easily broken by means of an external force.
- the bottle needle 8 is provided with an angled edge 8a, which cannot be easily drawn out once it is passed through a piercable section 11 mentioned later. Further, the middle portion of the cylindrical communicating section 9 is held by means of the boundary portion 1b.
- a glass or plastic vial or solute vessel 10, which constitutes a solute containing member, is housed in the housing chamber 3, and an antibiotic A as a powdered solute is contained in a chamber 10b in the vial 10.
- a mouth 10a of the vial 10 is fitted with a rubber stopper 11 for use as the piercable section through which the aforesaid bottle needle 8 can be run, and the stopper 11 is fixed by means of a mouthpiece 11a (Fig. 3).
- a bellows-like guide cover 12 is provided between the mouth 10a of the vial 10 and a bottom portion 3a of the housing chamber 3 defined by the boundary portion 1b as in Fig. 2. This guide cover 12 constitutes holding means.
- the guide cover 12 is formed of a material, e.g., a metal material such as aluminum or a thermoplastic resin such as polypropylene, which undergoes plastic deformation when subjected to an external force of a value greater than a predetermined value in the axial direction of the bottle needle 8, that is, in a direction such that the bottle needle 8 of the communicating section 9 pierces the rubber stopper 11 fitted in the mouth 10a of the vial 10, by an operator's hand, for example. Unless subjected to an axial force of a value greater than the predetermined value, therefore, the bottle needle 8 is kept at an off position, as shown in Fig. 3, in which it never pierces the rubber stopper 11, and the solution S cannot enter the vial 10 by mistake.
- a material e.g., a metal material such as aluminum or a thermoplastic resin such as polypropylene
- the bottle needle 8 is guided by the guide cover 12 so that it is prevented from misguidedly piercing any other object than the rubber stopper 11. Once the guide cover 12 is deformed and contracts, moreover, it maintains the deformed state as a result of the plastic deformation, so that the penetration of the bottle needle 8 can be secured.
- one end portion 12a of the guide cover 12 surrounds the mouth 10a of the vial and the rubber stopper 11 and is fixed to the vial 10.
- the other end portion 12b of the guide cover 12 extends in the axial direction of the bottle needle 8 so as to surround the needle, and is fixed to the bottom portion 3a.
- the guide cover 12 is blow-molded from the a thermoplastic resin, it can get better expansion and contraction because crest portions 12c of the guide cover 12, which project radially outward, are thinner than bottom portions 12d which are recessed radially inward, as shown in Fig. 3.
- the predetermined value of the external force which causes the plastic deformation of the guide cover 12 should be set to a value equal to or greater than the resistance against the needle 8 piercing the rubber stopper 11 of the vial 10, that is, piercing resistance.
- the predetermined value for the guide cover 12 is preferably set to 3 kgf as a minimum value.
- the upper limit of this predetermined value corresponds to the external force the operator can apply.
- the predetermined value is set within the range of 3 kgf to 5 kgf, preferably to 3.5 kgf.
- the guide cover 12 is formed from a metal material, the method of press-molding is preferably used.
- the package 4 covering the medicine storage container 1, as shown in Fig. 1, is removed.
- the bottle needle 8 of the communicating section 9 is run (see Fig. 4(a)) through the rubber stopper 11 in the mouth 10a of the vial 10 in the housing chamber 3 by axially contracting the guide cover 12 through plastic deformation by means of an external force of a value greater than the predetermined value.
- the closing section 7 of the communicating section 9 is broken or separated so that the vial 10 and the storage chamber 2 are caused to communicate by means of the communicating section 9 (see Fig. 4(b)).
- the solution S sealed in the storage chamber 2 is injected through the communicating section 9 into the vial 10 by holding the storage chamber 2 above the vial 10, whereby the powdered antibiotic A in the vial 10 is dissolved.
- the resulting solution of the powdered antibiotic A is returned to the storage chamber 2 by holding the vial 10 above the storage chamber 2. By repeating such operation, the powdered antibiotic A in the vial 10 is fully dissolved (see Fig. 4(c)).
- the medicine storage container 1 is hung on the hanger 14 of the transfusion stand 13 in a manner such that the hanger 14 is passed through the hole 1a of the medicine storage container 1 (see Fig. 4(d)).
- the medicine storage container 1 is hung on the hanger 14 so that the storage chamber 2, which contains the solution of the powdered antibiotic A, is on the bottom side.
- a transfusion set 15 comprises a bottle needle 16 piercing the discharge port 5, a drip cylinder 17, a clamp 18, an intravenous needle 19 to be stuck into a vein or the like of a patient M, and a tube 20 connecting these elements.
- the intravenous needle 19 of the transfusion set 15 is stuck into the vein or the like of the patient M, the bottle needle 16 is run through the discharge port 5 after removing the aluminum cap 6 fitted on the discharge port 5, and the clamp 18 is adjusted so that the solution of the powdered antibiotic A in the storage chamber 2 of the medicine storage container 1 can be administered to the patient M by an intravenous drip.
- the package 4 (Fig. 1) may be removed after the antibiotic A is dissolved in the solution S by the aforementioned piercing operation and before the setting on the transfusion stand 13.
- Fig. 5 shows another embodiment of the present invention. Since this embodiment is constructed substantially in the same manner as the embodiment shown in Fig. 2, like reference numerals are used to designate the same portions, and a description of those portions is omitted.
- the medicine storage container 1 comprises the storage chamber 2 and the housing chamber 3 which are integrally formed of the flexible synthetic resin sheet and are independent of each other. In the present embodiment, however, the storage chamber 2 and a housing chamber 30 are formed separately.
- the housing chamber 30 is in the form of a cylinder having a bellows-like portion 30a formed on the outer peripheral surface thereof.
- a hanging ring 21 is attached to an end face of the housing chamber 30.
- Other arrangements and functions of this embodiment are the same as those of the embodiment shown in Fig. 2, so that a description thereof is omitted.
- the bellows-like portion 30a serves to secure the axial plastic deformation of the guide cover 12 and the piercing state of the piercing element 8.
- the piercable section and the piercing element may be disposed on the storage-chamber side and on the solute-vessel side, respectively, in contrast with the arrangement of the storage chamber 2 and the solute vessel 10 disclosed in connection with the embodiments described above.
- various modifications may be effected in the present invention without departing from the scope of the claims.
- the separate storage container according to the present invention is suitably used as a drip bag adapted to be connected to a transfusion set, whereby a medicine is administered to a patient by an intravenous drip.
- the separate storage container of the invention may be also widely utilized in other fields where powdered or liquid solutes, as well as medicines, must be sterilely dissolved in solvents.
- the present invention may be applied to any other fields than the medical field in which medicines and the like are handled.
- the medicine storage container is disclosed as an example of the separate storage container of the present invention, in connection with the embodiments, the range of application of the invention is not limited to the field associated with "medicines" in a narrow sense.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mechanical Engineering (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Abstract
Description
- The present invention relates to a container for separately containing two or more substances, and more particularly, to a separate storage container in which a solvent, such as a solution, in a storage chamber is fed into a solute containing member which contains a solute, such as a powered or liquid medicine, so that the solute, such as the powdered or liquid medicine, can be mixed and sterilely dissolved.
- Many of medicines as solutes are dissolved in a solution for use as a solvent immediately before they are administered to a patient by an intravenous injection. There are various reasons for this. A typical reason in that the medicines can maintain their effect only for a short period of time after they are dissolved in the solution. When administering a powdered medicine, such as an antibiotic, contained in a solute vessel for use as a solute containing member, therefore, the following methods have conventionally been used in general.
- In a first example, a suitable amount of a solution, such as a physiological saline solution or 5 % grape sugar injection solution, is sucked in by means of an injector, and the needle of the injector is stuck into a solute vessel containing a powdered medicine, thereby injecting the solution. After the powdered medicine is dissolved, the solution is sucked in again to give a patient an injection.
- According to a second example, as is disclosed in Japanese Patent Disclosure No. 59-500600, for example, a solute vessel containing a powdered medicine and a bag stuffed with a solution are sterilely connected by means of an adapter which constitutes communication means holding a piercing needle and a frangible portion, the solution is injected into the solute vessel which contains the powdered medicine, thereby dissolving the powdered medicine, and the resulting solution is returned to the bag to subject a patient to an intravenous drip.
- In this case, moreover, a sleeve is given which is disposed so as to surround the piercing needle and is formed of a flexible material which expands and contracts as the needle moves.
- According to a third example, as is disclosed in U.S. Pat. No. 4,484, 920, moreover, a solute vessel containing a powdered medicine, a bag stuffed with a solution, and an empty bag are sterilely connected to one another by means of an adapter which includes a needle and a frangible portion. The solution is put into the solute vessel to dissolve the powdered medicine, whereupon an antibiotic or the like is fully dissolved by using the empty bag as an air vent. The resulting solution is returned to the bag to subject a patient to an intravenous drip.
- Also in this case, as in the case of the second example, a flexible, elastic sleeve or boot surrounding the piercing needle is given.
- However, the aforementioned prior art examples have various problems to be solved. In the case of the first example, vessels must be provided separately for the solution, injector, and powdered medicine, and must be operated in equipment for sterile work, such as a clean bench, so that the operation is troublesome, and there is a possibility of external bacterial contamination. In the case of the second example, there is no need of the sterile equipment, such as a clean bench, however, since no means is provided for positively keeping the prick portion of the solute vessel containing the powdered medicine separated from the piercing needle on the adapter when not in use in a normal state, so the solute vessel and the adapter may possibly be connected by mistake. When in use, moreover, the connecting operation is troublesome for an operator, and the construction of the adapter is complicated.
- In the case of the third example, moreover, no means is provided for positively keeping the piercing section of the solute vessel separated from the piercing needle on the adapter when not in use, just as in the case of the second example, so that the piercing section may possibly be unexpectedly pierced by mistake, thereby allowing the solute vessel and the adapter to be connected. In the case of this example, furthermore, the solution of the powdered medicine may enter the empty bag during use, and it is not easy to return the resulting solution to the bag containing the solution.
- A fourth example of an arrangement of a prior art storage container is described in US-A-4 589 879. The features common between this known arrangement and the invention are stated in the preamble of
claim 1. In this prior art a sleeve serving as holding element is provided to maintain the position of a removable piercing tip within a shank in cooperation with a membrane so that the piercing tip is to be removed from the shank only after piercing of a piercable element. However, the sleeve of this arrangement is not suited to avoid piercing of the piercable section by mistake or to secure the pierced state. - Accordingly, the object of the present invention is to provide a medicine storage container which eliminates the various problems of the prior art separate storage containers described above, and which,despite its simple construction, can positively keep a piercing section of one containing member containing one substance separated from a piercing element capable of piercing the piercing section as required, when not in use in a normal state, and can enable an operator to perform the piercing operation easily and securely, when in use, so that a chamber for the one containing member and a chamber for the other containing member containing the other substance are sterilely connected to effect required mixing (dissolution), and which is easy to handle.
- In order to achieve the above object, the present invention is based on the common arrangement disclosed in the second and third and fourth prior art examples.
- More specifically, the invention is premised on an arrangement which comprises the features of the preamble of
claim 1. - Based on the arrangement described above, according to the present invention, a separate storage container is proposed which is characterized by the features recited in the characterizing portion of
Claim 1. Preferred embodiments of the invention are described in the subclaims. - With the arrangement described above, the holding means can positively keep the piercing element of the communication means separated from the piercable section of the second containing member, so that an unexpected wrong piercing operation can be prevented. When in essential use, the holding means is plastically deformed by somewhat strongly applying the external force or an operator's manual force to a value greater than the predetermined value, so that the piercing operation can be effected, and the pierced state can be securely maintained by the plastically deformed holding means.
- Therefore, the holding means has a rigidity so as to be able to maintain its plastically deformed state when subjected to the above external force of a value greater than the predetermined value, thereby holding the pierced state of the piercing element.
- Thus, the separate storage container of the present invention is simple in construction due to its few components, and its communicating portion, which constitute the communication means, is sealed to be kept sterile. Further, a guide cover, which constitutes the holding means, cannot be plastically deformed unless it is subjected to an axial external force of a value greater than the predetermined value, so that a piercing needle, which constitutes the piercing element of the communicating portion, can hardly be unexpectedly run through the piercable section by mistake. Since there is no empty bag or the like, moreover, the dissolving operation is easy.
- According to a preferred specific arrangement of the present invention, the predetermined value of the external force to subject the holding means to the plastic deformation is set to be greater than the piercing resistance of the piercing element piercing the piercable section, e.g., to 3 kgf or more, preferably within the range of 3 kgf to 5 kgf, further preferably to 3.5 kgf.
- Preferably, moreover, the holding means is composed of a bellows-like guide cover integrally formed from thermoplastic resin by blow molding, for example. According to the blow molding, in particular, outwardly projecting crest portions of the bellows-like guide cover can be easily formed thinner than inwardly recessed bottom portions, so that a desirable property for the guide cover can be obtained.
- Other preferred specific arrangements and advantages of the present invention will be understood from the accompanying drawings and the following description taken in conjunction with the drawings.
-
- Figs. 1 to 4 show one embodiment of the present invention, in which Fig. 1 is a perspective view of a medicine storage container wrapped in a package, Fig. 2 is an enlarged perspective view of the medicine storage container with the package of Fig. 1 removed therefrom, Fig. 3 is an enlarged longitudinal sectional view of the medicine storage container shown in Fig. 2, especially portions corresponding to a guide cover and communication means and Fig. 4(a), 4(b), 4(c) and 4(d) are illustrative diagrams for individually showing states of operation of the medicine storage container; and
- Fig. 5 is a perspective view of a medicine storage container according to another embodiment of the present invention.
- Embodiments of the present invention will now be described in detail with reference to the accompanying drawings.
- Fig. 1 is a perspective view of a medicine storage container as a separate storage container of the present invention wrapped in a package, and Fig. 2 is a perspective view of the medicine storage container. In both these drawings,
numeral 1 denotes the medicine storage container, and themedicine storage container 1 comprises astorage chamber 2 and ahousing chamber 3 which are integrally formed of a flexible synthetic resin sheet and are independent of each other. Thismedicine storage container 1 is entirely covered by a rectangular package 4, which ensures the stability of a solution S (mentioned later) for use as a solvent sealed in thestorage chamber 2. Thestorage chamber 2 contains 50 to 100 ml of the solution S, e.g., a physiological saline solution or 5 % grape sugar solution. In Fig. 2, adischarge port 5 is provided at the lower portion of thestorage chamber 2, and further, analuminum cap 6 is fitted on thedischarge port 5 so that the solution S cannot run out. - A
hole 1a, which is used to hang thecontainer 1 on a hanger 14 of atransfusion stand 13 mentioned later, is formed at one end portion of the container, and aboundary portion 1b for dividing the twochambers section 9 as communication means is disposed between the upper portion of thestorage chamber 2 and the lower portion of thehousing chamber 3. The communicatingsection 9 has a separable closing section 7 located in thestorage chamber 2 and a bottle needle orpiercing needle 8 as a piercing element at the distal end thereof which is located in thehousing chamber 3. This communicating section is in the form of a cylinder closed at its end portion in thestorage chamber 2, and a notch is formed in the inner peripheral surface so that the closing section 7 can be easily broken by means of an external force. Thebottle needle 8 is provided with anangled edge 8a, which cannot be easily drawn out once it is passed through apiercable section 11 mentioned later. Further, the middle portion of the cylindrical communicatingsection 9 is held by means of theboundary portion 1b. A glass or plastic vial orsolute vessel 10, which constitutes a solute containing member, is housed in thehousing chamber 3, and an antibiotic A as a powdered solute is contained in achamber 10b in thevial 10. Amouth 10a of thevial 10 is fitted with arubber stopper 11 for use as the piercable section through which theaforesaid bottle needle 8 can be run, and thestopper 11 is fixed by means of amouthpiece 11a (Fig. 3). A bellows-like guide cover 12 is provided between themouth 10a of thevial 10 and abottom portion 3a of thehousing chamber 3 defined by theboundary portion 1b as in Fig. 2. Thisguide cover 12 constitutes holding means. Theguide cover 12 is formed of a material, e.g., a metal material such as aluminum or a thermoplastic resin such as polypropylene, which undergoes plastic deformation when subjected to an external force of a value greater than a predetermined value in the axial direction of thebottle needle 8, that is, in a direction such that thebottle needle 8 of the communicatingsection 9 pierces therubber stopper 11 fitted in themouth 10a of thevial 10, by an operator's hand, for example. Unless subjected to an axial force of a value greater than the predetermined value, therefore, thebottle needle 8 is kept at an off position, as shown in Fig. 3, in which it never pierces therubber stopper 11, and the solution S cannot enter thevial 10 by mistake. Further, thebottle needle 8 is guided by theguide cover 12 so that it is prevented from misguidedly piercing any other object than therubber stopper 11. Once theguide cover 12 is deformed and contracts, moreover, it maintains the deformed state as a result of the plastic deformation, so that the penetration of thebottle needle 8 can be secured. - As shown in Fig. 3, one end portion 12a of the
guide cover 12 surrounds themouth 10a of the vial and therubber stopper 11 and is fixed to thevial 10. The other end portion 12b of theguide cover 12 extends in the axial direction of thebottle needle 8 so as to surround the needle, and is fixed to thebottom portion 3a. - If the
guide cover 12 is blow-molded from the a thermoplastic resin, it can get better expansion and contraction becausecrest portions 12c of theguide cover 12, which project radially outward, are thinner thanbottom portions 12d which are recessed radially inward, as shown in Fig. 3. - It is to be desired that the predetermined value of the external force which causes the plastic deformation of the
guide cover 12 should be set to a value equal to or greater than the resistance against theneedle 8 piercing therubber stopper 11 of thevial 10, that is, piercing resistance. - Since the aforesaid piercing resistance is usually about 3 kgf, the predetermined value for the
guide cover 12, in this case, is preferably set to 3 kgf as a minimum value. the upper limit of this predetermined value corresponds to the external force the operator can apply. In consideration of the ease of operation, the predetermined value is set within the range of 3 kgf to 5 kgf, preferably to 3.5 kgf. - If the
guide cover 12 is formed from a metal material, the method of press-molding is preferably used. - Referring now to Fig. 4(a), 4(b), 4(c) and 4(d), how to use the
medicine storage container 1 with the aforementioned construction will be described. - First, the package 4 covering the
medicine storage container 1, as shown in Fig. 1, is removed. Then, thebottle needle 8 of the communicatingsection 9 is run (see Fig. 4(a)) through therubber stopper 11 in themouth 10a of thevial 10 in thehousing chamber 3 by axially contracting theguide cover 12 through plastic deformation by means of an external force of a value greater than the predetermined value. Futher, the closing section 7 of the communicatingsection 9 is broken or separated so that thevial 10 and thestorage chamber 2 are caused to communicate by means of the communicating section 9 (see Fig. 4(b)). Subsequently, the solution S sealed in thestorage chamber 2 is injected through the communicatingsection 9 into thevial 10 by holding thestorage chamber 2 above thevial 10, whereby the powdered antibiotic A in thevial 10 is dissolved. The resulting solution of the powdered antibiotic A is returned to thestorage chamber 2 by holding thevial 10 above thestorage chamber 2. By repeating such operation, the powdered antibiotic A in thevial 10 is fully dissolved (see Fig. 4(c)). - The
medicine storage container 1 is hung on the hanger 14 of the transfusion stand 13 in a manner such that the hanger 14 is passed through thehole 1a of the medicine storage container 1 (see Fig. 4(d)). In other words, themedicine storage container 1 is hung on the hanger 14 so that thestorage chamber 2, which contains the solution of the powdered antibiotic A, is on the bottom side. A transfusion set 15 comprises abottle needle 16 piercing thedischarge port 5, adrip cylinder 17, aclamp 18, anintravenous needle 19 to be stuck into a vein or the like of a patient M, and atube 20 connecting these elements. - As shown in Fig. 4(d), the
intravenous needle 19 of the transfusion set 15 is stuck into the vein or the like of the patient M, thebottle needle 16 is run through thedischarge port 5 after removing thealuminum cap 6 fitted on thedischarge port 5, and theclamp 18 is adjusted so that the solution of the powdered antibiotic A in thestorage chamber 2 of themedicine storage container 1 can be administered to the patient M by an intravenous drip. - The package 4 (Fig. 1) may be removed after the antibiotic A is dissolved in the solution S by the aforementioned piercing operation and before the setting on the
transfusion stand 13. - Fig. 5 shows another embodiment of the present invention. Since this embodiment is constructed substantially in the same manner as the embodiment shown in Fig. 2, like reference numerals are used to designate the same portions, and a description of those portions is omitted. In the embodiment shown in Fig. 2, the
medicine storage container 1 comprises thestorage chamber 2 and thehousing chamber 3 which are integrally formed of the flexible synthetic resin sheet and are independent of each other. In the present embodiment, however, thestorage chamber 2 and ahousing chamber 30 are formed separately. Thehousing chamber 30 is in the form of a cylinder having a bellows-like portion 30a formed on the outer peripheral surface thereof. A hangingring 21 is attached to an end face of thehousing chamber 30. Other arrangements and functions of this embodiment are the same as those of the embodiment shown in Fig. 2, so that a description thereof is omitted. The bellows-likeportion 30a serves to secure the axial plastic deformation of theguide cover 12 and the piercing state of the piercingelement 8. - According the present invention, the piercable section and the piercing element may be disposed on the storage-chamber side and on the solute-vessel side, respectively, in contrast with the arrangement of the
storage chamber 2 and thesolute vessel 10 disclosed in connection with the embodiments described above. Moreover, various modifications may be effected in the present invention without departing from the scope of the claims. - As described above, the separate storage container according to the present invention is suitably used as a drip bag adapted to be connected to a transfusion set, whereby a medicine is administered to a patient by an intravenous drip. However, the separate storage container of the invention may be also widely utilized in other fields where powdered or liquid solutes, as well as medicines, must be sterilely dissolved in solvents.
- Thus, the present invention may be applied to any other fields than the medical field in which medicines and the like are handled. Although the medicine storage container is disclosed as an example of the separate storage container of the present invention, in connection with the embodiments, the range of application of the invention is not limited to the field associated with "medicines" in a narrow sense.
Claims (14)
- A separate storage container comprising:
a first chamber (2) having a discharge port (5) and containing a first substance (S) therein;
a second chamber (10, 10b) containing a second substance (A) and a piercable section (11);
communication means (9) including a piercing element (8) capable of piercing the piercable section (11) of said second chamber (10, 10b) with a predetermined piercing resistance, and a closing section (7) extending into said first chamber (2) to cut off the communication between said first chamber (2) and the piercing element (8), said closing section (7) being separated after the piercable section (11) is pierced by said piercing element (8) so that said communication is allowed, whereby sterile communication between the first (2) and second (10, 10b) chambers is effected; and
holding means (12) disposed between said first (2) and second (10, 10b) chambers to surround said piercing element (8), said holding means (12) keeping the piercable section (11) of said second chamber (10, 10b) and the piercing element (8) separated, and undergoeing deformation in the axial direction of the piercing element (8) when subjected to an external force of a value greater than a predetermined value in said axial direction, thereby allowing the piercing element (8) to pierce said piercable section (11);
said separate storage container being characterized in that:
the deformation of the holding means (12) is a plastic deformation so that the pierced state can be maintained; and said predetermined value of the external force to subject said holding means (12) to the plastic deformation is greater than the piercing resistance of the piercing element (8) piercing the piercable section (11). - The separate storage container according to claim 1, characterized in that said predetermined value of the external force to subject said holding means (12) to the plastic deformation is 3 kgf or more.
- The separate storage container according to claim 1, characterized in that said predetermined value of the external force to subject said holding means (12) to the plastic deformation is set within the range of 3 kgf to 5 kgf, preferably to 3.5 kgf.
- The separate storage container according to any one of claims 1 to 3, characterized in that said holding means (12) is composed of a bellows-like guide cover.
- The separate storage container according to claim 4, characterized in that said guide cover (12) has one end portion (12a) surrounding the piercable section (11) of said second chamber (10, 10a) and fixed to said second chamber (10, 10a), and the other end portion (12b) axially extending from said one end portion (12a) so as to surround the piercing element (8) and fixed to a boundary portion (1b) dividing said first chamber (2) and the second chamber (10, 10a).
- The separate storage container according to claim 5, characterized in that said communication means (9) includes a central portion fixed liquid-tight to said boundary portion (1b) a distal end portion fitted with the piercing element, and a proximal end portion communicating with said closing section (7).
- The separate storage container according to claim 4 or 5, characterized in that said guide cover (12) is integrally formed from a thermoplastic resin by blow molding.
- The separate storage container according to claim 4 or 5, characterized in that outwardly projecting crest portions (12c) of said bellows-like guide cover (12) are thinner than inwardly recessed bottom portions (12d).
- The separate storage container according to claim 4 or 5, characterized in that said guide cover (12) is integrally formed from a metal material by the method of press molding.
- The separate storage container according to claim 1, characterized in that said first chamber (2) is formed from a synthetic resin sheet, and a housing chamber (3) housing said second chamber (10, 10b) is integrally formed in said sheet.
- The separate storage container according to claim 1, characterized in that said first chamber (2) is formed from a first synthetic resin sheet, and a housing chamber (3) housing said second chamber (10, 10b) is formed from a second synthetic resin sheet independent of said first sheet, said second sheet having a bellows-like portion on the outer peripheral surface thereof.
- The separate storage container according to claim 1, characterized in that said piercing element (8) is formed of a piercing needle having an angled edge (8a).
- The separate storage container according to claim 1, characterized in that said first substance is a solvent (S), said solvent being contained in a storage chamber constituting said first chamber (2), and said second substance is a solute (A) to be dissolved by said solvent, said solute being contained in said second chamber (10, 10b) located inside a housing chamber (3).
- The separate storage container according to claim 13, characterized in that said solvent (S) is a solution, and said solute (A) is a powdered medicine.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP243080/87 | 1987-09-28 | ||
JP24308087A JPS6485653A (en) | 1987-09-28 | 1987-09-28 | Drug receiving container |
PCT/JP1988/000980 WO1989002730A1 (en) | 1987-09-28 | 1988-09-27 | Separate storage container |
Publications (3)
Publication Number | Publication Date |
---|---|
EP0395758A1 EP0395758A1 (en) | 1990-11-07 |
EP0395758A4 EP0395758A4 (en) | 1990-12-27 |
EP0395758B1 true EP0395758B1 (en) | 1994-07-20 |
Family
ID=17098480
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP88908369A Expired - Lifetime EP0395758B1 (en) | 1987-09-28 | 1988-09-27 | Separate storage container |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0395758B1 (en) |
JP (1) | JPS6485653A (en) |
DE (1) | DE3850781T2 (en) |
WO (1) | WO1989002730A1 (en) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5776125A (en) | 1991-07-30 | 1998-07-07 | Baxter International Inc. | Needleless vial access device |
DE10005813A1 (en) * | 2000-02-10 | 2001-08-23 | Wolfgang Vilmar | Mixing unit comprises container which is housed in hollow cylinder in further, axially displaceable hollow cylinder provided at its lower end with rubber membrane |
US6582415B1 (en) | 1998-09-15 | 2003-06-24 | Thomas A. Fowles | Sliding reconstitution device for a diluent container |
US6610040B1 (en) | 1997-12-04 | 2003-08-26 | Baxter International Inc. | Sliding reconstitution device with seal |
US7923431B2 (en) | 2001-12-21 | 2011-04-12 | Ferrosan Medical Devices A/S | Haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis |
US7923031B2 (en) | 2004-01-30 | 2011-04-12 | Ferrosan Medical Devices A/S | Haemostatic sprays and compositions |
US7955288B2 (en) | 2002-12-11 | 2011-06-07 | Ferrosan Medical Devices A/S | Gelatine-based materials as swabs |
US8021684B2 (en) | 2004-07-09 | 2011-09-20 | Ferrosan Medical Devices A/S | Haemostatic composition comprising hyaluronic acid |
US8642831B2 (en) | 2008-02-29 | 2014-02-04 | Ferrosan Medical Devices A/S | Device for promotion of hemostasis and/or wound healing |
US9265858B2 (en) | 2012-06-12 | 2016-02-23 | Ferrosan Medical Devices A/S | Dry haemostatic composition |
EP3355847A4 (en) * | 2015-09-29 | 2019-07-03 | Siemens Medical Solutions USA, Inc. | Aseptic assembling of pharmaceutical containers |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5411499A (en) * | 1988-01-25 | 1995-05-02 | Baxter International Inc. | Needleless vial access device |
DE3834566A1 (en) * | 1988-10-11 | 1990-04-12 | Fresenius Ag | CONTAINER FOR STERILE, SEPARATE STORAGE OF AT LEAST TWO SUBSTANCES AND FOR MIXING THEREOF |
JPH077965Y2 (en) * | 1990-11-14 | 1995-03-01 | 昭和電工株式会社 | Infusion bag |
IT1251658B (en) * | 1991-10-07 | 1995-05-19 | Inge Spa | SINGLE USE DEVICE PREFERABLY FOR HYGIENE-SANITARY USE. |
US5352191A (en) * | 1991-10-25 | 1994-10-04 | Fujisawa Pharmaceutical Co., Ltd. | Transfusion device |
JPH05212090A (en) * | 1992-02-04 | 1993-08-24 | Material Eng Tech Lab Inc | Transfusion container |
JP3146465B2 (en) * | 1992-03-13 | 2001-03-19 | 株式会社ニッショー | Chemical injection device |
JP3256583B2 (en) * | 1992-12-10 | 2002-02-12 | 株式会社リコー | Electrophotographic toner and method for producing the same |
DE4314090C2 (en) * | 1993-04-29 | 1997-09-04 | Wolfgang Dr Vilmar | Medical cutlery for the manufacture of a drug solution |
US5547797A (en) * | 1993-08-05 | 1996-08-20 | Minolta Co., Ltd. | Developer for developing electrostatic latent images |
ES1037919Y (en) * | 1997-07-16 | 1998-11-01 | Inibsa Lab | TWO LIQUID CONTAINER CARTRIDGE. |
US5976115A (en) * | 1997-10-09 | 1999-11-02 | B. Braun Medical, Inc. | Blunt cannula spike adapter assembly |
US20050137566A1 (en) | 2003-12-23 | 2005-06-23 | Fowles Thomas A. | Sliding reconstitution device for a diluent container |
PL371200A1 (en) * | 2001-12-21 | 2005-06-13 | Ferrosan A/S | A haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis |
US7048724B2 (en) * | 2002-12-17 | 2006-05-23 | Denver Biomedicals, Inc. | Device for withdrawing body fluids |
WO2005030111A1 (en) | 2003-09-30 | 2005-04-07 | Coloplast A/S | A wound care device |
US7641851B2 (en) | 2003-12-23 | 2010-01-05 | Baxter International Inc. | Method and apparatus for validation of sterilization process |
DE102004021990B3 (en) * | 2004-05-04 | 2005-11-10 | Fresenius Kabi Deutschland Gmbh | Medical container for administering a liquid consisting of a carrier solution and a medicament comprises a chamber provided with means for delivery of the medicament into the chamber holding the carrier solution |
US7520919B2 (en) | 2004-06-22 | 2009-04-21 | Gambro Lundia Ab | Transducer-protector device for medical apparatus |
US8967374B2 (en) | 2006-05-18 | 2015-03-03 | Dr. Py Institute Llc | Delivery device with separate chambers connectable in fluid communication when ready for use, and related method |
FR2975302B1 (en) | 2011-05-18 | 2013-05-10 | Fresenius Medical Care De Gmbh | CONNECTOR FOR DIALYSIS CONTAINER, CONTAINER HAVING SUCH CONNECTOR, METHOD FOR MANUFACTURING AND FILLING SUCH CONNECTORS AND CONTAINERS |
FR2978914B1 (en) | 2011-08-11 | 2013-08-16 | Fresenius Medical Care De Gmbh | CONTAINER FOR DIALYSIS |
RU2616261C2 (en) * | 2011-12-29 | 2017-04-13 | Оцука Фармасьютикал Фэктори, Инк | Protective shall, portective module, equipped with such shell, medical solution supply system and method for medical solution delivery |
RU2657955C2 (en) | 2012-03-06 | 2018-06-18 | Ферросан Медикал Дивайсиз А/С | Pressurised container containing haemostatic paste |
US9724078B2 (en) | 2013-06-21 | 2017-08-08 | Ferrosan Medical Devices A/S | Vacuum expanded dry composition and syringe for retaining same |
CA2928963C (en) | 2013-12-11 | 2020-10-27 | Ferrosan Medical Devices A/S | Dry composition comprising an extrusion enhancer |
EP2962676B1 (en) | 2014-07-02 | 2017-03-22 | Paolo Gobbi Frattini S.r.l. | Flexible package with a sealed sterile chamber for the reconstitution and administration of fluid medicinal or nutritional substances instillable into the body of a patient |
CA2960309A1 (en) | 2014-10-13 | 2016-04-21 | Ferrosan Medical Devices A/S | Dry composition for use in haemostasis and wound healing |
JP6747650B2 (en) | 2014-12-24 | 2020-08-26 | フェロサン メディカル デバイシーズ エイ/エス | Syringe for holding and mixing the first substance and the second substance |
BR112017027695A2 (en) | 2015-07-03 | 2018-09-04 | Ferrosan Medical Devices As | first and second substance retention and mixing syringe |
JP7003493B2 (en) * | 2017-08-28 | 2022-02-04 | ニプロ株式会社 | Standard reagent kit for dialysate analysis |
JP6642339B2 (en) * | 2016-08-30 | 2020-02-05 | ニプロ株式会社 | Standard reagent kit for dialysate analysis |
EP3508840A4 (en) * | 2016-08-30 | 2020-04-15 | Nipro Corporation | Standard reagent kit for dialysis fluid analysis, and aqueous solution for standard reagent, dialysis fluid, and artificial kidney fluid replenishment |
EP3427781B1 (en) * | 2017-07-11 | 2024-09-25 | Pharma Resources GmbH | Drug and device system for pressurized aerosol therapies into a mammalian hollow space |
WO2019197650A1 (en) * | 2018-04-13 | 2019-10-17 | Fresenius Kabi Ab | Arrangement and method for providing a formulation for parenteral nutrition |
US20210015707A1 (en) * | 2018-04-13 | 2021-01-21 | Fresenius Kabi Ab | Container for a mixing system, mixing system for parenteral nutrition, and method for mixing |
CN112368028A (en) | 2018-05-09 | 2021-02-12 | 弗罗桑医疗设备公司 | Method for preparing a hemostatic composition |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS561559Y2 (en) * | 1976-08-12 | 1981-01-14 | ||
CA1171030A (en) * | 1979-11-05 | 1984-07-17 | David Bellamy | Fluid transfer assembly |
US4589879A (en) * | 1983-11-04 | 1986-05-20 | Baxter Travenol Laboratories, Inc. | Cannula assembly having closed, pressure-removable piercing tip |
JPS61260772A (en) * | 1985-05-14 | 1986-11-18 | Mitsubishi Electric Corp | Picture defect compensation device |
JPH0614708Y2 (en) * | 1989-10-17 | 1994-04-20 | ホシザキ電機株式会社 | Beverage warmer / cooler |
-
1987
- 1987-09-28 JP JP24308087A patent/JPS6485653A/en active Granted
-
1988
- 1988-09-27 EP EP88908369A patent/EP0395758B1/en not_active Expired - Lifetime
- 1988-09-27 WO PCT/JP1988/000980 patent/WO1989002730A1/en active IP Right Grant
- 1988-09-27 DE DE3850781T patent/DE3850781T2/en not_active Expired - Fee Related
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5776125A (en) | 1991-07-30 | 1998-07-07 | Baxter International Inc. | Needleless vial access device |
US6610040B1 (en) | 1997-12-04 | 2003-08-26 | Baxter International Inc. | Sliding reconstitution device with seal |
US6582415B1 (en) | 1998-09-15 | 2003-06-24 | Thomas A. Fowles | Sliding reconstitution device for a diluent container |
DE10005813A1 (en) * | 2000-02-10 | 2001-08-23 | Wolfgang Vilmar | Mixing unit comprises container which is housed in hollow cylinder in further, axially displaceable hollow cylinder provided at its lower end with rubber membrane |
US7923431B2 (en) | 2001-12-21 | 2011-04-12 | Ferrosan Medical Devices A/S | Haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis |
US8283320B2 (en) | 2001-12-21 | 2012-10-09 | Ferrosan Medical Devices A/S | Haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostasis |
US7955288B2 (en) | 2002-12-11 | 2011-06-07 | Ferrosan Medical Devices A/S | Gelatine-based materials as swabs |
US7923031B2 (en) | 2004-01-30 | 2011-04-12 | Ferrosan Medical Devices A/S | Haemostatic sprays and compositions |
US8021684B2 (en) | 2004-07-09 | 2011-09-20 | Ferrosan Medical Devices A/S | Haemostatic composition comprising hyaluronic acid |
US8642831B2 (en) | 2008-02-29 | 2014-02-04 | Ferrosan Medical Devices A/S | Device for promotion of hemostasis and/or wound healing |
US9533069B2 (en) | 2008-02-29 | 2017-01-03 | Ferrosan Medical Devices A/S | Device for promotion of hemostasis and/or wound healing |
US9265858B2 (en) | 2012-06-12 | 2016-02-23 | Ferrosan Medical Devices A/S | Dry haemostatic composition |
EP3355847A4 (en) * | 2015-09-29 | 2019-07-03 | Siemens Medical Solutions USA, Inc. | Aseptic assembling of pharmaceutical containers |
Also Published As
Publication number | Publication date |
---|---|
JPH0236261B2 (en) | 1990-08-16 |
DE3850781T2 (en) | 1995-02-23 |
EP0395758A1 (en) | 1990-11-07 |
DE3850781D1 (en) | 1994-08-25 |
JPS6485653A (en) | 1989-03-30 |
WO1989002730A1 (en) | 1989-04-06 |
EP0395758A4 (en) | 1990-12-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0395758B1 (en) | Separate storage container | |
EP0340880B1 (en) | Syringe | |
EP1323446B1 (en) | Syringe-type container for liquid medicine | |
US4568346A (en) | Hypodermic syringe having a telescopic assembly between cartridge and medicament holder | |
EP0282545B1 (en) | Connector and a disposable assembly utilizing said connector | |
US4861335A (en) | Syringe | |
US5718690A (en) | Hypodermic injector system and method for maintaining the sterility thereof prior to use | |
JP2988661B2 (en) | Fluid transfer device for accessing fluid from vials and ampules and method for transferring fluid using the device | |
JP4216466B2 (en) | Fluid transfer assembly | |
US20050075602A1 (en) | Device for reconstituting a therapeutic solution, suspension or dispersion | |
EP0598918A1 (en) | Medical container | |
US20010000347A1 (en) | Container closure system | |
JPH06239352A (en) | Solution injection set | |
WO2000063088A1 (en) | Cap for container and adaptor for liquid communication | |
WO1986005683A1 (en) | Transfer device | |
CA2071280A1 (en) | Transfer adaptors | |
CN112105328B (en) | Connector for connecting a medical injection device to a container | |
JP2002539891A (en) | Containers for packing medical liquids | |
JPS6072561A (en) | Two-drug component syringe having vein display capacity | |
AU771466B2 (en) | Membrane port for a container | |
US3938518A (en) | Syringe attachment device | |
EP2687199B1 (en) | Integrated puncture needle adapter | |
EP3562752B1 (en) | Container closure operated by rotation | |
JP3668293B2 (en) | Injection container | |
JPH04221567A (en) | Medical container |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19900327 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): BE DE FR GB IT SE |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 19901107 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): BE DE FR GB IT SE |
|
ITCL | It: translation for ep claims filed |
Representative=s name: FUMERO BREVETTI S.N.C. |
|
EL | Fr: translation of claims filed | ||
DET | De: translation of patent claims | ||
17Q | First examination report despatched |
Effective date: 19920619 |
|
RBV | Designated contracting states (corrected) |
Designated state(s): DE FR IT |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): DE FR IT |
|
REF | Corresponds to: |
Ref document number: 3850781 Country of ref document: DE Date of ref document: 19940825 |
|
ITF | It: translation for a ep patent filed | ||
ET | Fr: translation filed | ||
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed | ||
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20050823 Year of fee payment: 18 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20050922 Year of fee payment: 18 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20060930 Year of fee payment: 19 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20070403 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST Effective date: 20070531 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20061002 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20070927 |